
Congress trades
Safeguard Scientifics, Inc. (SFE)
NYSE · Financial Services · 7 congress trades · last filed 5 years agono longer trading under this ticker
About Safeguard Scientifics, Inc.
from the company's filings and listing- Exchange
- NYSE
- Sector
- Financial Services
- Industry
- Asset Management
- Chief executive
- Mark Dow
- Employees
- 33
- Listed since
- -
- Market value
- $7.5M
- Price to earnings
- -
- Earnings per share
- -$0.61
- Dividend yield
- 76.92%
Earnings
6 reported quarters · next on Mar 7, 2024| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q3 FY2023reported Nov 2, 2023 | $0.06 | n/a | $1.7M | n/a | EPS n/aRevenue n/a |
| Q2 FY2023reported Aug 10, 2023 | -$0.18 | n/a | -$166K | n/a | EPS n/aRevenue n/a |
| Q1 FY2023reported May 4, 2023 | -$0.22 | n/a | -$9K | n/a | EPS n/aRevenue n/a |
| Q4 FY2022reported Mar 9, 2023 | -$0.30 | n/a | -$3.3M | n/a | EPS n/aRevenue n/a |
| Q3 FY2022reported Nov 3, 2022 | -$0.19 | n/a | -$1.0M | n/a | EPS n/aRevenue n/a |
| Q2 FY2022reported Aug 11, 2022 | $0.03 | n/a | $30K | n/a | EPS n/aRevenue n/a |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Congress trades in SFE
7 disclosures of 7 on record · median 36d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Michael T. McCaulFiled late | Stock | Sale | $1,001 - $15,000 | -94.3%S&P +31.3% · vs S&P 500 -125.7% | Feb 2, 2021 | Mar 30, 2021 | 56d |
| Michael T. McCaul | Stock | Sale | $1,001 - $15,000 | -93.3%S&P +30.6% · vs S&P 500 -123.9% | Jan 26, 2021 | Feb 25, 2021 | 30d |
| Michael T. McCaul | Stock | Sale | $1,001 - $15,000 | -93.1%S&P +30.6% · vs S&P 500 -123.7% | Jan 20, 2021 | Feb 25, 2021 | 36d |
| Michael T. McCaul | Stock | Sale | $1,001 - $15,000 | -93.3%S&P +30.9% · vs S&P 500 -124.2% | Jan 22, 2021 | Feb 25, 2021 | 34d |
| Michael T. McCaul | Stock | Sale | $1,001 - $15,000 | -93.0%S&P +32.4% · vs S&P 500 -125.5% | Jan 14, 2021 | Feb 25, 2021 | 42d |
| Michael T. McCaul | Stock | Sale | $1,001 - $15,000 | -93.0%S&P +32.3% · vs S&P 500 -125.3% | Jan 19, 2021 | Feb 25, 2021 | 37d |
| Michael T. McCaul | Stock | Purchase | $50,001 - $100,000 | -93.0%S&P +34.8% · vs S&P 500 -127.7% | Dec 30, 2020 | Jan 25, 2021 | 26d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 6, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Questions
Which members of Congress have traded SFE?
Michael T. McCaul disclosed SFE transactions in the filings shown here.
How quickly are SFE trades disclosed?
Congressional disclosures took a median of 36 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.
